Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases

NCT02925351 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT02925351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02925351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1
Overall status
Completed
Start date
January 25, 2016
Completion date
April 30, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune disease, crohn disease, inflammatory disorder, rheumatoid arthritis, systemic lupus erythematosus, takayasu arteritis